Fig. 2From: Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastropheAnlotinib inhibited cell viability of proliferation. Three consecutive days of CCK-8 test showed Anlotinib suppressed cell proliferation in a dose-dependent pattern (a, b). Colony formation confirmed the inhibitive effect of Anlotinib. (c–f)(*p < 0.05, **p < 0.01)Back to article page